Adjuvant therapy guide for breast cancer

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Targeted therapy for breast cancer: Pros and cons

By Mayo Clinic staff

ProsCons
Reduces risk of recurrence by about half in early-stage HER2-positive breast cancer Not effective for breast cancers that are HER2-negative
  Increases risk of congestive heart failure
  Extraordinarily expensive, but usually covered by insurance
Combination therapy for breast cancer Targeted therapy for breast cancer

MY00202

Aug. 5, 2008

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.


Text Size: smaller largerlarger